These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3995361)

  • 1. Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesis.
    Pedigo NW; Brizzee KR
    Brain Res Bull; 1985 Feb; 14(2):169-77. PubMed ID: 3995361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional distribution of [3H]quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brainstem.
    Kinney HC; Panigrahy A; Rava LA; White WF
    J Comp Neurol; 1995 Nov; 362(3):350-67. PubMed ID: 8576444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem.
    Wamsley JK; Lewis MS; Young WS; Kuhar MJ
    J Neurosci; 1981 Feb; 1(2):176-91. PubMed ID: 7264716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of muscarinic cholinergic receptors in the dorsal vagal complex and other selected nuclei in the human medulla.
    Hyde TM; Gibbs M; Peroutka SJ
    Brain Res; 1988 May; 447(2):287-92. PubMed ID: 3390699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic muscarinic receptors in human fetal brain: ontogeny of [3H]quinuclidinyl benzilate binding sites in corpus striatum, brainstem, and cerebellum.
    Ravikumar BV; Sastry PS
    J Neurochem; 1985 Dec; 45(6):1948-50. PubMed ID: 4056800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting.
    Leslie RA; Shah Y; Thejomayen M; Murphy KM; Robertson HA
    Can J Physiol Pharmacol; 1990 Feb; 68(2):279-88. PubMed ID: 2311005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodose ganglionectomy selectively reduces muscarinic cholinergic and delta opioid binding sites in the dorsal vagal complex of the cat.
    Leslie RA; Murphy KM; Robertson HA
    Neuroscience; 1989; 32(2):481-92. PubMed ID: 2555741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C; Krause DN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
    Taniguchi T; Tsukahara T; Fujiwara M
    Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.
    Brunner F; Kukovetz WR
    J Cardiovasc Pharmacol; 1986; 8(4):712-21. PubMed ID: 2427809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ablation of area postrema on frequency and latency of motion sickness-induced emesis in the squirrel monkey.
    Brizzee KR; Ordy JM; Mehler WR
    Physiol Behav; 1980 May; 24(5):849-53. PubMed ID: 6773082
    [No Abstract]   [Full Text] [Related]  

  • 13. Motion-induced sickness following bilateral ablation of area postrema in squirrel monkeys.
    Wilpizeski CR; Lowry LD; Goldman WS
    Laryngoscope; 1986 Nov; 96(11):1221-5. PubMed ID: 3773620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for cholinergic vagal afferents and vagal presynaptic M1 receptors in the ferret.
    Reynolds DJ; Lowenstein PR; Moorman JM; Grahame-Smith DG; Leslie RA
    Neurochem Int; 1994 Nov; 25(5):455-64. PubMed ID: 7849574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
    Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
    Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem.
    Cortes R; Probst A; Palacios JM
    Neuroscience; 1984 Aug; 12(4):1003-26. PubMed ID: 6483188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of the muscarinic antagonist [3H]quinuclidinyl benzilate is not associated with preganglionic motor neurons in the dorsal motor nucleus of the vagus.
    Hodes ZI; Rea MA; Felten DL; Aprison MH
    Neurochem Res; 1983 Jan; 8(1):73-87. PubMed ID: 6856018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.